Ashwin Prakash, M.B.,B.S., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Progeria | 4 | 2024 | 185 | 2.700 |
Why?
|
Aorta | 12 | 2023 | 2061 | 2.270 |
Why?
|
Fontan Procedure | 18 | 2022 | 778 | 2.250 |
Why?
|
Magnetic Resonance Imaging, Cine | 12 | 2021 | 964 | 2.220 |
Why?
|
Connective Tissue Diseases | 5 | 2021 | 264 | 2.090 |
Why?
|
Heart Defects, Congenital | 27 | 2023 | 4584 | 2.080 |
Why?
|
Aortic Coarctation | 6 | 2020 | 281 | 1.900 |
Why?
|
Heart Ventricles | 18 | 2022 | 3821 | 1.390 |
Why?
|
Magnetic Resonance Angiography | 8 | 2021 | 1442 | 1.170 |
Why?
|
Aorta, Thoracic | 4 | 2017 | 1082 | 0.960 |
Why?
|
Tetralogy of Fallot | 3 | 2021 | 623 | 0.920 |
Why?
|
Collateral Circulation | 3 | 2013 | 287 | 0.850 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2021 | 143 | 0.770 |
Why?
|
Myocardium | 9 | 2023 | 4776 | 0.770 |
Why?
|
Pulmonary Artery | 7 | 2013 | 1912 | 0.760 |
Why?
|
Echocardiography | 17 | 2021 | 5102 | 0.740 |
Why?
|
Population Surveillance | 3 | 2018 | 2616 | 0.710 |
Why?
|
Pulmonary Veins | 4 | 2012 | 761 | 0.560 |
Why?
|
Hypoplastic Left Heart Syndrome | 5 | 2013 | 574 | 0.550 |
Why?
|
Heart | 7 | 2023 | 4467 | 0.540 |
Why?
|
Radiation Protection | 1 | 2018 | 419 | 0.500 |
Why?
|
Pulmonary Circulation | 4 | 2012 | 739 | 0.480 |
Why?
|
Stroke Volume | 11 | 2024 | 5007 | 0.460 |
Why?
|
Aortography | 1 | 2015 | 437 | 0.460 |
Why?
|
Mitral Valve | 2 | 2021 | 1491 | 0.450 |
Why?
|
Child | 43 | 2023 | 77709 | 0.450 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 546 | 0.450 |
Why?
|
Predictive Value of Tests | 14 | 2023 | 15076 | 0.440 |
Why?
|
Arteries | 1 | 2018 | 1119 | 0.440 |
Why?
|
Intracranial Aneurysm | 2 | 2020 | 1197 | 0.430 |
Why?
|
Cardiac Surgical Procedures | 6 | 2021 | 3537 | 0.420 |
Why?
|
Adolescent | 41 | 2022 | 85781 | 0.420 |
Why?
|
Ventricular Function, Left | 8 | 2022 | 3670 | 0.390 |
Why?
|
Risk Assessment | 9 | 2020 | 23338 | 0.380 |
Why?
|
Child, Preschool | 22 | 2018 | 41006 | 0.370 |
Why?
|
Heart Septal Defects | 1 | 2011 | 192 | 0.370 |
Why?
|
Angiography | 2 | 2013 | 1639 | 0.360 |
Why?
|
Hypertension | 2 | 2023 | 8480 | 0.350 |
Why?
|
Retrospective Studies | 29 | 2023 | 77449 | 0.350 |
Why?
|
Pleural Effusion | 1 | 2012 | 338 | 0.340 |
Why?
|
Tuberous Sclerosis | 3 | 2014 | 1029 | 0.330 |
Why?
|
Heart Transplantation | 4 | 2018 | 3110 | 0.320 |
Why?
|
Infant | 21 | 2021 | 35136 | 0.310 |
Why?
|
Mitral Valve Insufficiency | 3 | 2021 | 1422 | 0.310 |
Why?
|
Coronary Angiography | 2 | 2018 | 4577 | 0.300 |
Why?
|
Male | 58 | 2023 | 350118 | 0.290 |
Why?
|
Young Adult | 17 | 2023 | 56430 | 0.280 |
Why?
|
Ventricular Function | 3 | 2011 | 416 | 0.280 |
Why?
|
Vascular Surgical Procedures | 1 | 2015 | 1475 | 0.280 |
Why?
|
Exercise Tolerance | 1 | 2010 | 770 | 0.270 |
Why?
|
Echocardiography, Doppler | 3 | 2012 | 935 | 0.270 |
Why?
|
Scimitar Syndrome | 1 | 2005 | 31 | 0.270 |
Why?
|
Cardiology | 2 | 2023 | 1668 | 0.270 |
Why?
|
Magnetic Resonance Imaging | 15 | 2022 | 35421 | 0.260 |
Why?
|
Pacemaker, Artificial | 2 | 2023 | 816 | 0.260 |
Why?
|
Humans | 79 | 2024 | 744343 | 0.260 |
Why?
|
Female | 56 | 2023 | 380194 | 0.250 |
Why?
|
Observer Variation | 6 | 2018 | 2593 | 0.250 |
Why?
|
Arrhythmias, Cardiac | 4 | 2014 | 2268 | 0.250 |
Why?
|
Enalapril | 3 | 2011 | 327 | 0.250 |
Why?
|
Myocarditis | 2 | 2022 | 771 | 0.240 |
Why?
|
Aortic Valve | 3 | 2023 | 1922 | 0.240 |
Why?
|
Heart Septal Defects, Atrial | 3 | 2010 | 478 | 0.230 |
Why?
|
Heart Septal Defects, Ventricular | 2 | 2010 | 488 | 0.230 |
Why?
|
Adult | 26 | 2023 | 214055 | 0.230 |
Why?
|
Follow-Up Studies | 17 | 2022 | 39050 | 0.230 |
Why?
|
Blood Pressure | 2 | 2018 | 8554 | 0.230 |
Why?
|
Radiation Dosage | 3 | 2021 | 1928 | 0.220 |
Why?
|
Cross-Sectional Studies | 14 | 2022 | 25043 | 0.220 |
Why?
|
Age Factors | 8 | 2018 | 18370 | 0.220 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 4 | 2011 | 1518 | 0.200 |
Why?
|
Endovascular Procedures | 1 | 2015 | 1979 | 0.200 |
Why?
|
Marfan Syndrome | 2 | 2017 | 240 | 0.200 |
Why?
|
Body Surface Area | 2 | 2020 | 198 | 0.190 |
Why?
|
Renin-Angiotensin System | 2 | 2011 | 759 | 0.190 |
Why?
|
Reproducibility of Results | 12 | 2020 | 19905 | 0.190 |
Why?
|
Pulmonary Atresia | 2 | 2012 | 160 | 0.190 |
Why?
|
Palliative Care | 2 | 2013 | 3493 | 0.180 |
Why?
|
Heart Neoplasms | 2 | 2014 | 374 | 0.170 |
Why?
|
Gadolinium | 2 | 2022 | 952 | 0.170 |
Why?
|
Coronary Artery Disease | 1 | 2018 | 6487 | 0.160 |
Why?
|
Ventricular Dysfunction | 2 | 2010 | 143 | 0.160 |
Why?
|
Survival Rate | 3 | 2018 | 12788 | 0.160 |
Why?
|
Prospective Studies | 13 | 2023 | 53288 | 0.160 |
Why?
|
Heart Murmurs | 1 | 2018 | 94 | 0.160 |
Why?
|
Coronary Circulation | 1 | 2004 | 1572 | 0.150 |
Why?
|
Time Factors | 8 | 2021 | 40075 | 0.150 |
Why?
|
Loeys-Dietz Syndrome | 1 | 2017 | 40 | 0.150 |
Why?
|
Rhabdomyoma | 2 | 2014 | 57 | 0.150 |
Why?
|
Infant, Newborn | 15 | 2013 | 25625 | 0.140 |
Why?
|
Contrast Media | 5 | 2022 | 5300 | 0.140 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2017 | 89 | 0.140 |
Why?
|
Practice Guidelines as Topic | 2 | 2013 | 7279 | 0.140 |
Why?
|
Databases, Factual | 4 | 2018 | 7729 | 0.140 |
Why?
|
Risk Factors | 12 | 2020 | 72290 | 0.130 |
Why?
|
Stroke | 1 | 2018 | 9981 | 0.130 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3507 | 0.130 |
Why?
|
Postoperative Complications | 6 | 2014 | 15295 | 0.130 |
Why?
|
Middle Aged | 13 | 2018 | 213383 | 0.130 |
Why?
|
Coronary Occlusion | 1 | 2018 | 304 | 0.130 |
Why?
|
Electrocardiography | 6 | 2021 | 6442 | 0.120 |
Why?
|
Cerebral Angiography | 1 | 2020 | 1285 | 0.120 |
Why?
|
Prenatal Diagnosis | 3 | 2010 | 1236 | 0.120 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2014 | 153 | 0.120 |
Why?
|
Ventricular Remodeling | 1 | 2011 | 1224 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 5 | 2023 | 20129 | 0.110 |
Why?
|
Hemodynamics | 3 | 2013 | 4199 | 0.110 |
Why?
|
Down Syndrome | 1 | 2010 | 880 | 0.110 |
Why?
|
Bundle-Branch Block | 1 | 2014 | 270 | 0.110 |
Why?
|
Heart Valve Prosthesis | 1 | 2021 | 1488 | 0.100 |
Why?
|
Exercise Test | 4 | 2011 | 2074 | 0.100 |
Why?
|
Growth Disorders | 2 | 2011 | 645 | 0.100 |
Why?
|
Incidence | 4 | 2018 | 20947 | 0.100 |
Why?
|
Severity of Illness Index | 4 | 2017 | 15540 | 0.100 |
Why?
|
Linear Models | 3 | 2015 | 5952 | 0.100 |
Why?
|
Prognosis | 6 | 2021 | 29063 | 0.100 |
Why?
|
Postoperative Period | 3 | 2011 | 1842 | 0.100 |
Why?
|
Angioplasty, Balloon | 1 | 2015 | 653 | 0.100 |
Why?
|
Prevalence | 3 | 2018 | 15226 | 0.100 |
Why?
|
Heart Diseases | 1 | 2004 | 2788 | 0.090 |
Why?
|
Gadolinium DTPA | 2 | 2014 | 836 | 0.090 |
Why?
|
Treatment Outcome | 15 | 2021 | 63114 | 0.090 |
Why?
|
Systole | 1 | 2013 | 958 | 0.090 |
Why?
|
Endomyocardial Fibrosis | 1 | 2010 | 41 | 0.090 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2021 | 1536 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2020 | 1956 | 0.090 |
Why?
|
Cardiac Imaging Techniques | 2 | 2023 | 269 | 0.090 |
Why?
|
Health Status | 4 | 2011 | 4034 | 0.090 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12245 | 0.090 |
Why?
|
Oxygen Consumption | 2 | 2010 | 1869 | 0.080 |
Why?
|
Ventricular Function, Right | 1 | 2013 | 591 | 0.080 |
Why?
|
Diastole | 2 | 2009 | 791 | 0.080 |
Why?
|
Boston | 3 | 2020 | 9313 | 0.080 |
Why?
|
Cardiac Volume | 1 | 2009 | 210 | 0.080 |
Why?
|
Norwood Procedures | 1 | 2010 | 182 | 0.080 |
Why?
|
Regional Blood Flow | 1 | 2012 | 1525 | 0.080 |
Why?
|
Algorithms | 5 | 2014 | 13881 | 0.080 |
Why?
|
Funnel Chest | 1 | 2008 | 71 | 0.080 |
Why?
|
Situs Inversus | 1 | 2007 | 64 | 0.080 |
Why?
|
Cardiomyopathy, Hypertrophic, Familial | 1 | 2007 | 66 | 0.080 |
Why?
|
Heart Valve Diseases | 1 | 2015 | 1073 | 0.070 |
Why?
|
Sex Factors | 2 | 2018 | 10397 | 0.070 |
Why?
|
Sensitivity and Specificity | 4 | 2014 | 14722 | 0.070 |
Why?
|
Odds Ratio | 2 | 2015 | 9849 | 0.070 |
Why?
|
Longitudinal Studies | 1 | 2023 | 13989 | 0.070 |
Why?
|
Health Care Costs | 1 | 2020 | 3209 | 0.070 |
Why?
|
Pulmonary Valve | 1 | 2011 | 437 | 0.070 |
Why?
|
United States | 6 | 2018 | 69872 | 0.070 |
Why?
|
Parents | 2 | 2009 | 3407 | 0.060 |
Why?
|
Reference Values | 2 | 2020 | 4982 | 0.060 |
Why?
|
Feasibility Studies | 2 | 2005 | 5078 | 0.060 |
Why?
|
Logistic Models | 2 | 2015 | 13408 | 0.060 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 1107 | 0.060 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2004 | 72 | 0.060 |
Why?
|
North America | 2 | 2018 | 1249 | 0.060 |
Why?
|
Tissue Survival | 1 | 2004 | 118 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 12959 | 0.060 |
Why?
|
Polymorphism, Genetic | 2 | 2011 | 4328 | 0.060 |
Why?
|
Chi-Square Distribution | 3 | 2010 | 3508 | 0.060 |
Why?
|
Stents | 1 | 2015 | 3280 | 0.060 |
Why?
|
Myocardial Contraction | 2 | 2010 | 1585 | 0.060 |
Why?
|
Iron Overload | 1 | 2005 | 242 | 0.050 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2011 | 1573 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2014 | 21746 | 0.050 |
Why?
|
beta-Thalassemia | 1 | 2005 | 225 | 0.050 |
Why?
|
Registries | 1 | 2018 | 8089 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10262 | 0.050 |
Why?
|
Aldosterone | 2 | 2011 | 877 | 0.050 |
Why?
|
Birth Weight | 1 | 2010 | 2069 | 0.050 |
Why?
|
Tachycardia, Ventricular | 1 | 2010 | 1273 | 0.050 |
Why?
|
Heart Atria | 1 | 2007 | 1357 | 0.050 |
Why?
|
Length of Stay | 3 | 2021 | 6309 | 0.050 |
Why?
|
Angiotensins | 1 | 2011 | 151 | 0.050 |
Why?
|
Infant, Premature | 1 | 2010 | 2044 | 0.050 |
Why?
|
Attitude to Health | 1 | 2009 | 2052 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 2009 | 2418 | 0.050 |
Why?
|
Abnormalities, Multiple | 1 | 2007 | 1416 | 0.040 |
Why?
|
Oximetry | 1 | 2003 | 471 | 0.040 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2010 | 364 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2011 | 365 | 0.040 |
Why?
|
Blood Flow Velocity | 1 | 2003 | 1423 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 634 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2011 | 12026 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2010 | 3327 | 0.040 |
Why?
|
Renin | 1 | 2011 | 642 | 0.040 |
Why?
|
Kidney Function Tests | 1 | 2011 | 684 | 0.040 |
Why?
|
Recovery of Function | 1 | 2009 | 2925 | 0.040 |
Why?
|
Pericardium | 2 | 2018 | 667 | 0.040 |
Why?
|
Aged | 3 | 2018 | 163280 | 0.040 |
Why?
|
Phantoms, Imaging | 1 | 2006 | 2480 | 0.040 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2009 | 2073 | 0.040 |
Why?
|
Internationality | 1 | 2013 | 1003 | 0.040 |
Why?
|
Troponin | 1 | 2021 | 524 | 0.040 |
Why?
|
Education, Medical, Graduate | 1 | 2010 | 2291 | 0.040 |
Why?
|
Radiography | 2 | 2005 | 7023 | 0.040 |
Why?
|
Markov Chains | 1 | 2020 | 969 | 0.040 |
Why?
|
Genetic Testing | 2 | 2014 | 3444 | 0.040 |
Why?
|
Iron | 1 | 2005 | 1774 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2029 | 0.030 |
Why?
|
Nomograms | 1 | 2017 | 228 | 0.030 |
Why?
|
Canada | 1 | 2010 | 2065 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2020 | 1184 | 0.030 |
Why?
|
Reoperation | 2 | 2010 | 4201 | 0.030 |
Why?
|
Graft Rejection | 1 | 2008 | 4397 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2021 | 2110 | 0.030 |
Why?
|
Sample Size | 1 | 2017 | 845 | 0.030 |
Why?
|
Clinical Competence | 1 | 2010 | 4687 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2020 | 1683 | 0.030 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2008 | 789 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2018 | 57776 | 0.030 |
Why?
|
Endothelium, Vascular | 2 | 2019 | 4456 | 0.030 |
Why?
|
Phenotype | 3 | 2019 | 16365 | 0.030 |
Why?
|
Disease Management | 1 | 2013 | 2459 | 0.030 |
Why?
|
Heart Rate | 2 | 2008 | 4091 | 0.030 |
Why?
|
Hospital Mortality | 2 | 2010 | 5317 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2008 | 1240 | 0.030 |
Why?
|
Up-Regulation | 1 | 2011 | 4217 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2022 | 3760 | 0.030 |
Why?
|
Europe | 1 | 2018 | 3339 | 0.020 |
Why?
|
Genotype | 2 | 2011 | 12951 | 0.020 |
Why?
|
Ventricular Septum | 1 | 2011 | 73 | 0.020 |
Why?
|
Ontario | 1 | 2011 | 383 | 0.020 |
Why?
|
Fibroma | 1 | 2011 | 212 | 0.020 |
Why?
|
Liver | 1 | 2005 | 7474 | 0.020 |
Why?
|
Preoperative Period | 1 | 2011 | 549 | 0.020 |
Why?
|
Teratoma | 1 | 2011 | 395 | 0.020 |
Why?
|
Heart Conduction System | 1 | 2014 | 1047 | 0.020 |
Why?
|
Cohort Studies | 3 | 2012 | 40561 | 0.020 |
Why?
|
Survival Analysis | 2 | 2014 | 10252 | 0.020 |
Why?
|
Heart Bypass, Right | 1 | 2008 | 74 | 0.020 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2011 | 585 | 0.020 |
Why?
|
Research Design | 2 | 2018 | 5987 | 0.020 |
Why?
|
Critical Care | 1 | 2010 | 2647 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2010 | 1420 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5391 | 0.020 |
Why?
|
Infant, Small for Gestational Age | 1 | 2010 | 440 | 0.020 |
Why?
|
Dilatation, Pathologic | 1 | 2008 | 520 | 0.020 |
Why?
|
Heart Failure | 1 | 2010 | 10900 | 0.020 |
Why?
|
Hemangioma | 1 | 2011 | 738 | 0.020 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2010 | 349 | 0.020 |
Why?
|
Regression Analysis | 2 | 2008 | 6459 | 0.020 |
Why?
|
Hemoglobin E | 1 | 2005 | 6 | 0.020 |
Why?
|
Consensus | 1 | 2014 | 2959 | 0.020 |
Why?
|
Massachusetts | 1 | 2018 | 8663 | 0.020 |
Why?
|
Infant, Low Birth Weight | 1 | 2010 | 850 | 0.020 |
Why?
|
Hemosiderin | 1 | 2005 | 43 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1677 | 0.020 |
Why?
|
Chelation Therapy | 1 | 2005 | 67 | 0.020 |
Why?
|
Endocardium | 1 | 2006 | 263 | 0.020 |
Why?
|
Quality of Life | 2 | 2020 | 12804 | 0.020 |
Why?
|
Deferoxamine | 1 | 2005 | 151 | 0.020 |
Why?
|
Biomedical Engineering | 1 | 2006 | 296 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2011 | 1257 | 0.010 |
Why?
|
Organ Size | 1 | 2009 | 2252 | 0.010 |
Why?
|
Iron Chelating Agents | 1 | 2005 | 139 | 0.010 |
Why?
|
Hospitals, Pediatric | 1 | 2012 | 1775 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6895 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2010 | 9959 | 0.010 |
Why?
|
Image Enhancement | 1 | 2014 | 2921 | 0.010 |
Why?
|
DNA Primers | 1 | 2007 | 2892 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2010 | 2170 | 0.010 |
Why?
|
Ferritins | 1 | 2005 | 590 | 0.010 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2007 | 859 | 0.010 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2008 | 780 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6365 | 0.010 |
Why?
|
Gestational Age | 1 | 2010 | 3493 | 0.010 |
Why?
|
Syndrome | 1 | 2007 | 3251 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2010 | 2046 | 0.010 |
Why?
|
Gene Frequency | 1 | 2007 | 3588 | 0.010 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2003 | 277 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12354 | 0.010 |
Why?
|
Body Weight | 1 | 2010 | 4669 | 0.010 |
Why?
|
Pregnancy | 2 | 2010 | 29144 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2003 | 2373 | 0.010 |
Why?
|
Alleles | 1 | 2007 | 6933 | 0.010 |
Why?
|
Base Sequence | 1 | 2007 | 12797 | 0.010 |
Why?
|
Comorbidity | 1 | 2010 | 10388 | 0.010 |
Why?
|
Pilot Projects | 1 | 2008 | 8324 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 17446 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2005 | 8642 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13695 | 0.010 |
Why?
|
Models, Biological | 1 | 2005 | 9583 | 0.000 |
Why?
|
Animals | 1 | 2014 | 168757 | 0.000 |
Why?
|